Search - tctmd.com

Displaying 81 - 100 of 118

Sort: Relevancy | Date

News Daily News

Atrial Fibrillation Risk Increased in People With Asthma

Michael O'Riordan

July 13, 2018

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

L.A. McKeown

July 10, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

Yael L. Maxwell

May 18, 2018

News Conference News HRS 2018

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

Todd Neale

May 10, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Yael L. Maxwell

November 28, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Conference News ESC 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Todd Neale

September 05, 2017

Podcast TCTMD Talking Points

Episode 28: The AMULET Observational Study

August 23, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Daily News

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Michael O'Riordan

March 31, 2017

Advertisement

Atrial Fibrillation Risk Increased in People With Asthma

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

New Review Probes Possibility of CVD Prevention Without Aspirin

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Live From Denver: TCT 2017, Day Four

NOAC Bleeding Risk Rises With Several Drug Combinations

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Episode 28: The AMULET Observational Study

Betrixaban Approved for Prevention of VTE

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content